Evidence-based pharmacotherapy of panic disorder: an update
- PMID: 21733234
- DOI: 10.1017/S1461145711000800
Evidence-based pharmacotherapy of panic disorder: an update
Abstract
The evidence-based pharmacotherapy of panic disorder continues to evolve. This paper reviews data on first-line pharmacotherapy, evidence for maintenance treatment, and management options for treatment-refractory patients. A Medline search of research on pharmacotherapy was undertaken, and a previous systematic review on the evidence-based pharmacotherapy of panic disorder was updated. Selective serotonin reuptake inhibitors remain a first-line pharmacotherapy of panic disorder, with the serotonin noradrenaline reuptake inhibitor venlafaxine also an acceptable early option. Temporary co-administration of benzodiazepines can be considered. Maintenance treatment reduces relapse rates, but further research to determine optimal duration is needed. For patients not responding to first-line agents several pharmacotherapy options are available, but there is a notable paucity of data on the optimal choice.
Similar articles
-
Evidence-based pharmacotherapy of panic disorder.Int J Neuropsychopharmacol. 2005 Sep;8(3):473-82. doi: 10.1017/S1461145705005201. Epub 2005 Mar 30. Int J Neuropsychopharmacol. 2005. PMID: 15804373 Review.
-
Medication discontinuation in panic disorder.J Clin Psychiatry. 1992 Mar;53 Suppl:26-31. J Clin Psychiatry. 1992. PMID: 1548252 Review.
-
International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):27S-31S. doi: 10.1097/00004714-199812001-00006. J Clin Psychopharmacol. 1998. PMID: 9872710
-
Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder.J Affect Disord. 2002 May;69(1-3):201-8. doi: 10.1016/s0165-0327(01)00359-7. J Affect Disord. 2002. PMID: 12103467
-
Relapse prevention in panic disorder with pharmacotherapy: where are we now?Expert Opin Pharmacother. 2020 Oct;21(14):1699-1711. doi: 10.1080/14656566.2020.1779220. Epub 2020 Jun 16. Expert Opin Pharmacother. 2020. PMID: 32543949
Cited by
-
Synthesis of Optimized Molecularly Imprinted Polymers for the Isolation and Detection of Antidepressants via HPLC.Biomimetics (Basel). 2019 Feb 20;4(1):18. doi: 10.3390/biomimetics4010018. Biomimetics (Basel). 2019. PMID: 31105203 Free PMC article.
-
Benzodiazepines versus placebo for panic disorder in adults.Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD010677. doi: 10.1002/14651858.CD010677.pub2. Cochrane Database Syst Rev. 2019. PMID: 30921478 Free PMC article.
-
Anticipatory anxiety of seizures: What is the best treatment?Epilepsy Behav Rep. 2024 May 8;27:100673. doi: 10.1016/j.ebr.2024.100673. eCollection 2024. Epilepsy Behav Rep. 2024. PMID: 38841320 Free PMC article.
-
Antidepressants and benzodiazepines for panic disorder in adults.Cochrane Database Syst Rev. 2016 Sep 12;9(9):CD011567. doi: 10.1002/14651858.CD011567.pub2. Cochrane Database Syst Rev. 2016. PMID: 27618521 Free PMC article. Review.
-
Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders.Gen Hosp Psychiatry. 2020 Jan-Feb;62:21-27. doi: 10.1016/j.genhosppsych.2019.11.005. Epub 2019 Nov 17. Gen Hosp Psychiatry. 2020. PMID: 31765794 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical